Equillium (EQ) Capital Expenditures (2018 - 2026)
Equillium (EQ) posted quarterly Capital Expenditures of $3000.0 for Q1 2026, down 25.0% year-over-year from $4000.0 in Q1 2025, and down 93.18% quarter-over-quarter from $44000.0 in Q4 2025.
Powered by 
Analysis
Equillium (EQ) Capital Expenditures (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Capital Expenditures for 9 consecutive years, with $3000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 25.0% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $47000.0 (down 32.86% YoY), while the FY2025 annual figure was $48000.0, down 43.53% from the prior year.
- Capital Expenditures eased to $3000.0 in Q1 2026 per EQ's latest filing, from $44000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $276000.0 in Q4 2022 and bottomed at -$274000.0 in Q3 2022.
- Historically, Capital Expenditures has averaged $40909.1 across 5 years, with a median of $35000.0 in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 956.25% — and 2025, when it soared 1000.0%.
- Equillium's Capital Expenditures stood at $276000.0 in 2022, then sank by 87.32% to $35000.0 in 2023, then plunged by 88.57% to $4000.0 in 2024, then jumped by 1000.0% to $44000.0 in 2025, then sank by 93.18% to $3000.0 in 2026.
- Business Quant data shows EQ's Capital Expenditures at $3000.0 in Q1 2026, $44000.0 in Q4 2025, and $4000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Dec 31, 2020 | 30,000.00 |
| Sep 30, 2020 | 157,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Jun 30, 2019 | 43,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Sep 30, 2018 | 3,000.00 |